Overview and Scope
Stem cell manufacturing refers to the necessary technologies that allow stem cell tissue culture, a practice carried out in laboratories for therapeutic purposes, to be transferred to the clinic setting while simultaneously achieving control, reproducibility, automation, validation, and product safety.
Sizing and Forecast
The stem cell manufacturing market size has grown rapidly in recent years. It will grow from $15.78 billion in 2023 to $17.39 billion in 2024 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to advancements in biotechnology, research and development initiatives, clinical trials and therapeutic applications, regulatory framework establishment, investment in infrastructure..
The stem cell manufacturing market size is expected to see rapid growth in the next few years. It will grow to $26.55 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to increased funding and investments, growing therapeutic applications, emergence of cell-based therapies, rise in clinical trials and approvals, customized and patient-specific therapies.. Major trends in the forecast period include focus on 3d bioprinting, expansion in induced pluripotent stem cells (ipscs), automation and robotics integration, standardization and scalability, bioreactor technology advancements..
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/stem-cell-manufacturing-global-market-report
Segmentation & Regional Insights
The stem cell manufacturing market covered in this report is segmented –
1) By Product: Consumables, Instruments, Stem Cell Lines
2) By Application: Research Applications, Clinical Application, Cell and Tissue Banking Applications
3) By End User: Pharmaceutical And Biotechnology Companies, Academic Institutes, Research Laboratories And Contract Research Organizations, Hospitals And Surgical Centers, Cell And Tissue Banks, Other End Users
North America was the largest region in the stem cell manufacturing market in 2023. Europe was the second-largest region in the stem cell manufacturing market. The regions covered in the stem cell manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9402&type=smp
Major Driver Impacting Market Growth
The rise in geriatric population is expected to propel the stem cell manufacturing market. The geriatric population refers to older adults who are 65 years old and beyond. The geriatric population suffers from various diseases due to low immunity and age. Aging increases the risk of chronic diseases and stem cell manufacturing will help in fighting against these diseases. For instance, according to the United Nations Department of Economic and Social Affairs’ September 2020 report, a part of the United Nations Secretariat, the population aged 65 and above is projected to rise from 9.3% in 2020 to around 16.0% in 2050. Furthermore, according to October 2021 factsheet published by World Health Organization, a Switzerland-based international public health agency, there will be 1.4 billion individuals over the age of 60 in the world by 2030, up from 1 billion in 2020. Thus, the rising geriatric population is driving the growth of the stem cell manufacturing market.
Key Industry Players
Major companies operating in the stem cell manufacturing market are focused on developing innovative products, such as GM-grade protein, to gain a competitive edge in the market. GM-grade protein is a designation given to protein powders and other protein products that meet certain standards for quality and safety. For instance, in November 2023, ACROBiosystems Inc., a US-based provider of recombinant proteins and other critical reagents, launched GM-grade DLL4 protein. It is a recombinant, soluble form of Delta-like Ligand 4 (DLL4), a key signaling molecule critical in stem cell development and differentiation. The availability of GMP-grade DLL4 is a significant milestone for developing stem cell-based therapies, as it provides a high-quality, consistent, and scalable source of this important protein. DLL4 is known to promote the self-renewal and expansion of hematopoietic stem cells (HSCs), which are the precursors to all blood cells and can be used to supplement stem cell cultures in vitro, thereby enhancing the growth and differentiation of HSCs.
The stem cell manufacturing market report table of contents includes:
1. Executive Summary
2. Stem Cell Manufacturing Market Characteristics
3. Stem Cell Manufacturing Market Trends And Strategies
4. Stem Cell Manufacturing Market – Macro Economic Scenario
5. Global Stem Cell Manufacturing Market Size and Growth
.
.
.
31. Global Stem Cell Manufacturing Market Competitive Benchmarking
32. Global Stem Cell Manufacturing Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Stem Cell Manufacturing Market
34. Stem Cell Manufacturing Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report
https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report
https://www.thebusinessresearchcompany.com/report/monoclonal-antibodies-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
